Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Valencia-Serna

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nanomedicine (London, England)|April 14, 2016
Fibronectin-modified surfaces for evaluating the influence of cell adhesion on sensitivity of leukemic cells to siRNA nanoparticlesJuliana Valencia-Serna, Pascale Chevallier, Remant Bahadur Kc, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2013
Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulationJuliana Valencia-Serna, Hilal Gul-Uludağ, Parvin Mahdipoor, et al.
Drug Discovery Today|April 30, 2016
Current attempts to implement siRNA-based RNAi in leukemia modelsHasan Uludağ, Breanne Landry, Juliana Valencia-Serna, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2017
Nucleic acid combinations: A new frontier for cancer treatmentRemant Bahadur K C, Bindu Thapa, Juliana Valencia-Serna, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 19, 2018
siRNA/lipopolymer nanoparticles to arrest growth of chronic myeloid leukemia cells in vitro and in vivoJuliana Valencia-Serna, Hamidreza M Aliabadi, Adam Manfrin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 21, 2019
siRNA-mediated BCR-ABL silencing in primary chronic myeloid leukemia cells using lipopolymersJuliana Valencia-Serna, Cezary Kucharski, Min Chen, et al.
Journal of Biomedical Materials Research. Part A|November 13, 2019
Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapyK C Remant, Bindu Thapa, Juliana Valencia-Serna, et al.
Molecular Therapy. Nucleic Acids|May 13, 2015
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid LeukemiaBreanne Landry, Juliana Valencia-Serna, Hilal Gul-Uludag, et al.
Drug Discovery Today|May 19, 2019
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic optionsDaniel Nisakar Meenakshi Sundaram, Xiaoyan Jiang, Joseph M Brandwein, et al.
Molecular Pharmaceutics|October 21, 2010
Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroidsStephanie J Grainger, Juliana Valencia Serna, Steffi Sunny, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nanomedicine (London, England)|April 14, 2016
Fibronectin-modified surfaces for evaluating the influence of cell adhesion on sensitivity of leukemic cells to siRNA nanoparticlesJuliana Valencia-Serna, Pascale Chevallier, Remant Bahadur Kc, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2013
Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulationJuliana Valencia-Serna, Hilal Gul-Uludağ, Parvin Mahdipoor, et al.
Drug Discovery Today|April 30, 2016
Current attempts to implement siRNA-based RNAi in leukemia modelsHasan Uludağ, Breanne Landry, Juliana Valencia-Serna, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2017
Nucleic acid combinations: A new frontier for cancer treatmentRemant Bahadur K C, Bindu Thapa, Juliana Valencia-Serna, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 19, 2018
siRNA/lipopolymer nanoparticles to arrest growth of chronic myeloid leukemia cells in vitro and in vivoJuliana Valencia-Serna, Hamidreza M Aliabadi, Adam Manfrin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 21, 2019
siRNA-mediated BCR-ABL silencing in primary chronic myeloid leukemia cells using lipopolymersJuliana Valencia-Serna, Cezary Kucharski, Min Chen, et al.
Journal of Biomedical Materials Research. Part A|November 13, 2019
Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapyK C Remant, Bindu Thapa, Juliana Valencia-Serna, et al.
Molecular Therapy. Nucleic Acids|May 13, 2015
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid LeukemiaBreanne Landry, Juliana Valencia-Serna, Hilal Gul-Uludag, et al.
Drug Discovery Today|May 19, 2019
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic optionsDaniel Nisakar Meenakshi Sundaram, Xiaoyan Jiang, Joseph M Brandwein, et al.
Molecular Pharmaceutics|October 21, 2010
Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroidsStephanie J Grainger, Juliana Valencia Serna, Steffi Sunny, et al.
Pageof 2